Are you a US healthcare provider?

This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.

If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.

Receive Updates on Our Pipeline

Overview of Our Medicines in Development

Watch Max Lataillade, VP, Head of Global Research Strategy, talk about our pipeline and where these developmental medicines target the HIV lifecycle.

Watch Now

Overview of Our Medicines in Development

X

Development Pipeline by Class

bnAb

NRTTIs

Capsid Inhibitor

  • VH400280

    Class: Capsid Inhibitor

    Phase: I

  • VH401499

    Class: Capsid Inhibitor

    Phase: Pre-clinical

INSTI

Maturation inhibitors

Our compounds in development target various stages of the HIV lifecycle

Select each stage below to view where our pipeline products target the HIV lifecycle.